GET DAILY SIGNALSCarpenter Technology (CRS) Delivers Record Earnings Beat but Revenue Miss Triggers -20% Share Drop
Key Takeaways
- Carpenter Technology posted diluted earnings per share (EPS) of $3.25, beating the analyst consensus of roughly $3.03 to $3.04.
- Net sales reached $798.2 million, up 9% year over year, but fell short of the $830.7 million consensus estimate.
- Operating income of $196.4 million rose 28% from the prior-year period, a record first quarter for the company.
- The Specialty Alloys Operations (SAO) segment maintained a 37.7% adjusted operating margin, matching its prior-quarter record.
- Shares dropped roughly 20% on the day as investors focused on the revenue miss despite the earnings beat.
Earnings Context and Why It Matters
CRS is a leading producer of premium specialty alloys, serving the aerospace, defense, medical, and energy markets. Its fiscal first quarter, ended September 30, 2026, is a key signal for how the aerospace supply chain is absorbing rising aircraft build rates and growing demand for nickel superalloys. Coming off a stretch of expanding margins and strong pricing, this report tests whether the company can sustain momentum while navigating planned maintenance downtime and elevated capital spending. For investors, the quarter matters because it sets the tone for the rest of fiscal 2027 and offers early evidence on whether record profitability can coexist with revenue growth that meets Wall Street's expectations.
Breaking Down the Reported Results
For the first quarter of fiscal 2027, CRS reported net sales of $798.2 million, a 9% increase from $733.7 million a year earlier but below the consensus estimate of approximately $830.7 million. Net sales excluding surcharge, a measure that strips out raw material pass-through costs, rose 5% year over year to $634.8 million. Diluted EPS came in at $3.25, up from $2.43 in the prior-year quarter and ahead of the roughly $3.03 to $3.04 consensus. I also checked this using Tickeron’s AI Screener to see how the stock compares to others in the industry.
Operating income reached $196.4 million, up 28% year over year and a record for a first quarter. Within the segments, the Specialty Alloys Operations (SAO) business generated $216.3 million in operating income with an adjusted operating margin of 37.7%, matching its prior-quarter record. The Performance Engineered Products (PEP) segment posted operating income of $7.3 million, down from $9.4 million a year earlier, reflecting softer titanium sales into the medical market.
Cash from operations was $52.8 million, while capital expenditures of $77.7 million drove negative free cash flow of $24.8 million. The company repurchased $133.9 million of stock and authorized a new $1 billion buyback program. For the second quarter, management guided total operating income to a range of $192 million to $197 million.
Market Reaction and Investor Sentiment
The market's response to CRS results was decidedly negative despite the earnings beat. Shares fell roughly 20% to 22% in trading following the release, with the decline driven largely by the revenue shortfall relative to consensus. Investors appeared to weigh the sequential sales decline, which management attributed to planned preventive maintenance outages, more heavily than the record operating income. One thing that stands out is how elevated expectations left little room for any top-line disappointment, even as margins and profitability held up strongly.
Forward Outlook and Key Factors to Monitor
Looking ahead, CRS guidance points to continued strength in profitability, with second-quarter operating income expected in the range of $192 million to $197 million. Management reiterated an industry-leading financial outlook and set a fiscal 2029 operating income target of approximately $1.2 billion to $1.3 billion, implying a 20%+ compound annual growth rate over three years. I’m watching this closely as aerospace demand remains a central catalyst, with bookings in the aerospace distribution and structural sub-markets rising 23% sequentially and 49% year over year.
The recent Federal Aviation Administration approval of the Boeing 737 MAX 10 is viewed by management as another demand accelerant for the supply chain. Investors should also watch the defense sub-market, where sales and bookings have lagged due to funding uncertainty that management expects to clarify after the U.S. midterm elections. On the cost side, elevated capital expenditures tied to the brownfield capacity expansion are pressuring free cash flow in the near term, even as the company targets $400 million to $430 million in free cash flow for fiscal 2027. Capacity uptime, pricing on nickel superalloys, and execution in the medical-focused PEP segment will be key swing factors in the quarters ahead.
Using Tickeron’s AI Tools in My Research
In my analysis of specialty metals names like CRS, I regularly rely on Tickeron’s AI Screener to quickly surface comparable setups and technical patterns across the sector. The tool allows me to apply filters for fundamentals, volatility, and AI signals, helping me cross-check earnings momentum against peers without spending hours on manual reviews. It has become a practical part of my routine when evaluating whether a quarter’s results signal broader industry trends or isolated factors.
Disclaimer
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
Contributor
Sergey Savastiouk, Ph.D. has a degree in Applied Mathematics from Moscow University and has extensive experience as an entrepreneur, investor, manager, and mathematician. His professional expertise is in applied mathematics, mathematical modeling, system and pattern analysis, and software and hardware system integration. He has served as the CEO of several hi-tech start-up companies and nonprofit organizations, which has given him proven capabilities in business strategy for high-tech start-up companies, market assessment, company formation, team building, product development, marketing, and sales. He has published numerous articles in journals and magazines on related fields. As a retail investor, he spent 15 years developing his proprietary trading and quantitative algorithms (now Tickeron’s A.I.), which brought him significant returns in trading the stock market. His current work and goal in founding Tickeron is to bring professional, sophisticated stock market analysis capabilities to retail investors via an easy-to-use interface.
CRS sees its Stochastic Oscillator recovers from oversold territory
On October 15, 2026, the Stochastic Oscillator for CRS moved out of oversold territory and this could be a bullish sign for the stock. Traders may want to buy the stock or buy call options. Tickeron's A.I.dvisor looked at 47 instances where the indicator left the oversold zone. In 40 of the 47 cases the stock moved higher in the following days. This puts the odds of a move higher at over 85%.
Technical Analysis (Indicators)
Bullish Trend Analysis
The RSI Indicator demonstrates that the ticker has stayed in the oversold zone for 1 day, which means it's wise to expect a price bounce in the near future.
The Moving Average Convergence Divergence (MACD) for CRS just turned positive on September 29, 2026. Looking at past instances where CRS's MACD turned positive, the stock continued to rise in 31 of 38 cases over the following month. The odds of a continued upward trend are 82%.
Following a +1.86% 3-day Advance, the price is estimated to grow further. Considering data from situations where CRS advanced for three days, in 281 of 348 cases, the price rose further within the following month. The odds of a continued upward trend are 81%.
CRS may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
Bearish Trend Analysis
Following a 3-day decline, the stock is projected to fall further. Considering past instances where CRS declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 75%.
The Aroon Indicator for CRS entered a downward trend on October 21, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
Fundamental Analysis (Ratings)
The Tickeron PE Growth Rating for this company is 30 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Profit vs. Risk Rating rating for this company is 35 (best 1 - 100 worst), indicating well-balanced risk and returns. The average Profit vs. Risk Rating rating for the industry is 73, placing this stock slightly better than average.
The Tickeron SMR rating for this company is 37 (best 1 - 100 worst), indicating strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Price Growth Rating for this company is 61 (best 1 - 100 worst), indicating fairly steady price growth. CRS’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Valuation Rating of 84 (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: CRS's P/B Ratio (8.191) is slightly higher than the industry average of (3.125). P/E Ratio (34.765) is within average values for comparable stocks, (10.154). Projected Growth (PEG Ratio) (1.380) is also within normal values, averaging (0.744). Dividend Yield (0.002) settles around the average of (0.029) among similar stocks. P/S Ratio (6.645) is also within normal values, averaging (5901.087).
The Tickeron Seasonality Score of 95 (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.
Industry description
Market Cap
High and low price notable news
Volume
Fundamental Analysis Ratings
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
Advertisement
Search Optimization Top 10 Day Trading and Swing Trading Bots
AI Trading Bots: Top 10 Day Traders, Signals Only, on November 12 , 2024
Principal Financial Group (PFG) Stock Surges 5.18% in July 2025: What Drove the Rally and What’s Next?
Revolutionizing AI Trading: How the HUBB AI Trading Bot Achieves strong performance with 5-Minute Precision
How Financial Learning Models Help Investors Outperform the S&P 500
General Information
a manufacturer of specialty metals
Industry MetalFabrication
Advertisement